Navigation Links
Elanco Expands Parasiticide Portfolio in US with New Product for Heartworm Disease, Intestinal Parasites

GREENFIELD, Ind., Oct. 28, 2015 /PRNewswire/ -- Elanco Animal Health has launched Interceptor® Plus (milbemycin oxime/praziquantel) in the United States. Interceptor Plus is a monthly chewable tablet that prevents heartworm disease caused by Dirofilaria immitis and protects against intestinal parasites including adult hookworm (Ancylostoma caninum), adult roundworm (Toxocara canis, Toxascaris leonina), adult whipworm (Trichuris vulpis) and adult tapeworm (Taenia pisiformis, Echinococcus multilocularis and Echinococcus granulosus) in dogs.

Interceptor Plus is chicken flavored, making it a good choice for dogs with beef allergies. Dosing is easy, with more than 96% overall acceptability. It is safe for use in dogs and puppies 6 weeks of age and older that weigh 2 pounds or more.

"Interceptor Plus is a great choice for dog owners with active, outdoor dogs," according to Dr. Stephen Connell, Director, Technical, Academic and Consumer Services. "Dogs that play in dog parks or frequently visit boarding or grooming facilities where they interact with other dogs also can benefit from Interceptor Plus."

Interceptor Plus is approved by the FDA and available only through veterinarians. The product is supported by an Elanco product guarantee. "This is another product that supports Elanco's commitment to helping pets live longer, healthier, higher-quality lives," Connell said.

Elanco, a division of Eli Lilly and Company, provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. With a global presence of approximately 7,000 people and offices in more than 40 countries, Elanco anticipates, serves and supports the diverse and evolving needs of its customers — from veterinarians to food producers to all those concerned with animal health — to help them address the challenges of a diverse and changing world. Together with our customers, we are committed to raising awareness about global food security and celebrating and supporting the human-animal bond. Additional information about Elanco is available at or follow us @Elanco.

Important Safety Information
Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. Prior to administration of Interceptor Plus, dogs should be tested for existing heartworm infections. The safety of Interceptor Plus has not been evaluated in dogs used for breeding or in lactating females. The following adverse reactions have been reported in dogs after administration of milbemycin oxime or praziquantel: vomiting, diarrhea, depression/lethargy, ataxia, weight loss, convulsions, weakness, and salivation. Please see full product information below.

Interceptor, Elanco and the diagonal bar are trademarks owned by or licensed to Eli Lilly and Company, its affiliates or subsidiaries.

© Eli Lilly and Company, its affiliates or subsidiaries. USCAHINP00019


Christina Gaines, Elanco, 317-276-3845Sharon Polk, McCormick Company, 816-584-8444


Photo -


SOURCE Elanco Animal Health
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Animal Health Market 2014-2018: Key Vendors are Bayer, Elanco, Merck Animal Health, Merial and Zoetis
2. Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis
3. Actinobac Biomed, Inc. signs technology licensing agreement with Elanco
4. Europe to Lead the Global Veterinary Healthcare Market- Zoetis, Merck, Merial, Elanco Animal Health, Bayer Animal Health Among the Major Players
5. Lehigh Valley Expands Fleet of Superbug-Slaying Robots
6. Avillion Expands Leadership Team with Appointment of Ramani Varanasi as Chief Business Officer
7. Fortune 500 Pharmaceutical Company Expands Use of inContact Cloud Contact Center Software Across Multiple Divisions
8. BioDrain Breaks into National Network of Ambulatory Surgical Centers and Expands Installations of its STREAMWAY System throughout the U.S.
9. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
10. Edison Expands North American Healthcare Sector Coverage With Initiation of Coverage on Bellus Health
11. NextDocs Expands Customer Roster by More Than 10 Percent
Post Your Comments:
(Date:7/2/2020)... ... July 02, 2020 , ... ... distributor, is pleased to announce its donation of more than $190,000 in personal ... of Health and Human Services. As extreme medical shortages continue to plague the ...
(Date:7/1/2020)... Va. (PRWEB) , ... July 01, 2020 , ... ... edition of The International Business Awards® is Tuesday, July 28. ... business awards competition. In 2019 the competition attracted more than 4,000 nominations ...
(Date:7/1/2020)... ... July 01, 2020 , ... Stratodesk ... NoTouch OS is available on NComputing devices. Thanks to fantastic new growth and ... have formed a new partnership that will make the full Stratodesk NoTouch OS ...
Breaking Medicine Technology:
(Date:6/28/2020)... , ... June 26, 2020 , ... ... Detox, the Inland Empire’s premier residential addiction treatment center, proudly announces that it ... now includes special preparation for recovery in a world affected by Covid-19. , ...
(Date:6/28/2020)... , ... June 27, 2020 , ... ... Classroom, the first online, full-day educational conference in the organization’s history. The online ... facioscapulohumeral muscular dystrophy (FSHD), which was cancelled this year due to COVID-19. Nearly ...
(Date:6/25/2020)... ... , ... Denials Management, Inc. has just published The Health Insurance Appeals Guide ... denials of mental health and substance use disorder (MH/SUD) treatment services. It was written ... explain the steps in the appeals process. Complimentary copies of the Guide can ...
(Date:6/24/2020)... ... ... Dr. Katinka van der Merwe, the creator of the world’s leading 12 week ... Grace podcast. She explains her outside-the-box, holistic approach to treating CRPS and how important ... diagnosed with CRPS about 10 years ago, Amberly Lago , the host of ...
(Date:6/24/2020)... ... 2020 , ... Skyroam , the developer of patented virtual SIM (vSIM) ... leading provider of enterprise software for testing laboratories, in which its Skyroam Solis Lite ... Disease Surveillance Lab (PDSL) kit. , “Stopping the spread of COVID-19 is a global ...
Breaking Medicine News(10 mins):